Ochre Bio

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases, one of the top ten global killers. We leverage advances in "deep phenotyping" to uncover novel biological pathways, then study our drugs on human livers kept alive on machines. By doing so, Ochre Bio ensures that the medicines we bring to the clinic have a high likelihood of successfully improving patients' lives. Located at the heart of Oxford University's Biotech Innovation Hub, Ochre Bio’s scientific roots trace back over 15 years of leading liver genomics research and experience in bringing advanced therapies to market.